A ‘living GLP-1 drug’ could revolutionize diabetes treatment
Bacteria engineered to sense and reduce glucose levels could be the future of type 2 diabetes treatments, following pre-clinical trials on animal models.Continue ReadingCategory: Diabetes, Illnesses and conditions, Body and Mind, Refractor: Science & HealthTags: Type 2 diabetes, GLP-1 receptor agonists, Weight Loss, Probiotic, Diet
This is a summary aggregated from New Atlas. Read the complete article on the original site:
Read full article at New Atlas
